Crouse Steven C. bought TECH
June 2, 2026 · Form 4 insider transaction
Crouse Steven C. bought 600 shares of Bio-Techne Corporation, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
600
Price
N/A
Total value
N/A
InsiderCrouse Steven C.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 2, 2026
Filing dateJune 4, 2026
Shares owned after6,977
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.; Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person.